Ideology may not be the only factor driving Betsy McCaughey’s propaganda campaign against two health care provisions in the stimulus bill.
As Health Care Renewal points out, “not noted in Betsy McCaughey’s op-ed article was that she is currently on the board of directors of Cantel Medical, a device company, and formerly on the board of Genta, a biotechnology company.”
In fact, according to a Statement of Changes in Beneficial Ownership Securities from the Securities and Exchange Commission, McCaughey received 750 Shares of stock options just days before writing the Bloomberg op-ed. Then, the total worth of the shares was approximately $11,250:
Should she have disclosed this information to her readers? Well, as Health Care Renewal explains, up to now “we have left industry to fund, control, and too often suppress and manipulate clinical research about its own products, so that the results are better at putting particular products in a good light.” Should independent research dispute the effectiveness of a Cantel Medical product, McCaughey and Cantel could face serious financial loses.


Your blog will be full if you report SEC filings from key insiders.
February 14th, 2009 at 12:06 pmStart with Susan Bayh, the wife of Senator Evan Bayh.
February 14th, 2009 at 12:06 pmThis woman is a sham.
Betsy McCaughey helped kill universal health care 16 years ago. Back then, she led the charge against the Clinton plan to cover every single American. Given that the pharma companies and device makers shower her with money, is it any surprise she is working for their interests and against the American people? It’s alarming that the mainstream media has not exposed her conflicts of interest.
February 17th, 2009 at 10:26 am